Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Sullivan

Showing results (91-100 of 106) with videos related to

Pageof 11
Sort By:
Heart, Lung & Circulation|January 27, 2023
Australian Atherosclerosis Society Position Statement on Lipoprotein(a): Clinical and Implementation RecommendationsNatalie C Ward, Gerald F Watts, Warrick Bishop, et al.
Diabetes Research and Clinical Practice|February 23, 2026
Chronic complication risk and benefits of fenofibrate in type 2 diabetes by a PPARα polymorphism (rs6008845, C/T): a FIELD trial substudyAndrzej S Januszewski, Michael L H Huang, Abubakar Mangani, et al.
The Lancet. Diabetes & Endocrinology|March 3, 2018
Effect of fenofibrate on uric acid and gout in type 2 diabetes: a post-hoc analysis of the randomised, controlled FIELD studyBoris Waldman, Jean-Claude Ansquer, David R Sullivan, et al.
European Heart Journal|June 19, 2019
Development and validation of a ceramide- and phospholipid-based cardiovascular risk estimation score for coronary artery disease patientsMika Hilvo, Peter J Meikle, Eva Ringdal Pedersen, et al.
Journal of Atherosclerosis and Thrombosis|March 28, 2017
Design of the Familial Hypercholesterolaemia Australasia Network Registry: Creating Opportunities for Greater International CollaborationMatthew I Bellgard, Caroline E Walker, Kathryn R Napier, et al.
JCI Insight|September 7, 2018
Large-scale plasma lipidomic profiling identifies lipids that predict cardiovascular events in secondary preventionPiyushkumar A Mundra, Christopher K Barlow, Paul J Nestel, et al.
Circulation|October 21, 2016
Plasma Lipidomic Profiles Improve on Traditional Risk Factors for the Prediction of Cardiovascular Events in Type 2 Diabetes MellitusZahir H Alshehry, Piyushkumar A Mundra, Christopher K Barlow, et al.
International Journal of Cardiology|January 15, 2014
Integrated guidance on the care of familial hypercholesterolaemia from the International FH FoundationGerald F Watts, Samuel Gidding, Anthony S Wierzbicki, et al.
Journal of Atherosclerosis and Thrombosis|June 4, 2014
Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation: executive summaryGerald F Watts, Samuel Gidding, Anthony S Wierzbicki, et al.
European Journal of Preventive Cardiology|April 30, 2014
Integrated guidance on the care of familial hypercholesterolaemia from the International FH FoundationGerald F Watts, Samuel Gidding, Anthony S Wierzbicki, et al.
Pageof 11

Showing results (91-100 of 106) with videos related to

Sort By:
Pageof 11
Heart, Lung & Circulation|January 27, 2023
Australian Atherosclerosis Society Position Statement on Lipoprotein(a): Clinical and Implementation RecommendationsNatalie C Ward, Gerald F Watts, Warrick Bishop, et al.
Diabetes Research and Clinical Practice|February 23, 2026
Chronic complication risk and benefits of fenofibrate in type 2 diabetes by a PPARα polymorphism (rs6008845, C/T): a FIELD trial substudyAndrzej S Januszewski, Michael L H Huang, Abubakar Mangani, et al.
The Lancet. Diabetes & Endocrinology|March 3, 2018
Effect of fenofibrate on uric acid and gout in type 2 diabetes: a post-hoc analysis of the randomised, controlled FIELD studyBoris Waldman, Jean-Claude Ansquer, David R Sullivan, et al.
European Heart Journal|June 19, 2019
Development and validation of a ceramide- and phospholipid-based cardiovascular risk estimation score for coronary artery disease patientsMika Hilvo, Peter J Meikle, Eva Ringdal Pedersen, et al.
Journal of Atherosclerosis and Thrombosis|March 28, 2017
Design of the Familial Hypercholesterolaemia Australasia Network Registry: Creating Opportunities for Greater International CollaborationMatthew I Bellgard, Caroline E Walker, Kathryn R Napier, et al.
JCI Insight|September 7, 2018
Large-scale plasma lipidomic profiling identifies lipids that predict cardiovascular events in secondary preventionPiyushkumar A Mundra, Christopher K Barlow, Paul J Nestel, et al.
Circulation|October 21, 2016
Plasma Lipidomic Profiles Improve on Traditional Risk Factors for the Prediction of Cardiovascular Events in Type 2 Diabetes MellitusZahir H Alshehry, Piyushkumar A Mundra, Christopher K Barlow, et al.
International Journal of Cardiology|January 15, 2014
Integrated guidance on the care of familial hypercholesterolaemia from the International FH FoundationGerald F Watts, Samuel Gidding, Anthony S Wierzbicki, et al.
Journal of Atherosclerosis and Thrombosis|June 4, 2014
Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation: executive summaryGerald F Watts, Samuel Gidding, Anthony S Wierzbicki, et al.
European Journal of Preventive Cardiology|April 30, 2014
Integrated guidance on the care of familial hypercholesterolaemia from the International FH FoundationGerald F Watts, Samuel Gidding, Anthony S Wierzbicki, et al.
Pageof 11